Recent studies indicate a significant rise in adult diagnoses of attention-deficit hyperactivity disorder (ADHD), with many attributing this increase to heightened awareness and societal changes following the pandemic. According to Rochell Sharpe Hultz, a nurse practitioner at Blessing Health System, the uptick can partly be traced to the reduced stigma surrounding mental health issues, particularly influenced by the proliferation of social media.
Hultz defines ADHD as "a neurocognitive problem or disorder" affecting daily life, with symptoms often becoming apparent early on, typically around age seven. "It’s almost like you’re driven by a motor," she explains, noting the restlessness and fidgeting tendencies often seen in affected individuals.
The need for accurate diagnosis is emphasized by Hultz, who assesses patients' childhood histories, including learning disabilities and household stability, to determine if ADHD is present. A comprehensive 2023 study shows ADHD medication prescriptions have surged, reflecting the increase in diagnoses among adults.
"I think the mental illness stigma is much less than it used to be. People are more open about having discussions about their issues or their problems," remarked Hultz. This openness, fueled by social media conversations, may encourage individuals to seek evaluations and treatments for ADHD.
The economic impact of adult ADHD is significant. Hultz cites research indicating annual costs averaging $14,092 per individual due to medication, insurance, lab costs, and lost productivity. Altogether, ADHD leads to approximately $122.8 billion lost annually due to factors such as unemployment and decreased work productivity, underscoring the disorder's far-reaching consequences.
Adult ADHD symptoms often manifest not only at work but also at home, contributing to absenteeism and poor time management. Hultz mentions signs like trouble focusing, daydreaming, and being easily distractible, which can complicate daily tasks like household chores or punctuality for appointments.
Recent statistics reveal around 15.5 million U.S. adults are diagnosed with ADHD, with nearly half receiving their diagnosis as adults. Alarmingly, about one third do not actively pursue treatments. Hultz notes the importance of considering environmental and genetic factors when assessing ADHD, including potential lead exposure and unstable home environments.
Treatment options for those diagnosed with ADHD often begin with medication, where stimulants are considered the standard choice. Hultz prefers to explore non-stimulant options initially, especially for patients new to ADHD management. Alongside pharmacological interventions, she advocates for practical daily changes, such as establishing color-coded organization systems and structured meal planning, to reduce decision-making stress.
"Creating a rigid schedule can alleviate those with ADHD of the mental stress caused by daily decisions," Hultz explains, demonstrating how small shifts can lead to significant quality-of-life improvements for individuals dealing with ADHD.
This rise in adult ADHD diagnoses since 2020 indicates not only greater recognition of the disorder but also the necessity for support systems and effective treatments for adults grappling with its challenges.